Cargando…
Remimazolam – current knowledge on a new intravenous benzodiazepine anesthetic agent
Intravenous anesthetic agents such as midazolam, propofol, and ketamine are routinely used to provide anesthesia and sedation. They have been shown to effectively induce and maintain amnesia, sedation, and hypnosis in various patient groups and clinical settings. However, all anesthetic agents have...
Autores principales: | Kim, Seong-Hyop, Fechner, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Anesthesiologists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346281/ https://www.ncbi.nlm.nih.gov/pubmed/35585830 http://dx.doi.org/10.4097/kja.22297 |
Ejemplares similares
-
The effect of repetitive exposure to intravenous anesthetic agents on the immunity in mice
por: Park, Hyun Jun, et al.
Publicado: (2020) -
Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent
por: Kilpatrick, Gavin J.
Publicado: (2021) -
Characterization of intracellular calcium mobilization induced by remimazolam, a newly approved intravenous anesthetic
por: Urabe, Tomoaki, et al.
Publicado: (2022) -
An anesthetic experience with remimazolam for MELAS patients
por: Kitaura, Atsuhiro, et al.
Publicado: (2022) -
Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil
por: Yoshida, Akari, et al.
Publicado: (2021)